• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    GlaxoSmithKline plc (GSK)

    -NYSE
    47.42 Down 0.42(0.88%) Feb 27, 4:04PM EST
    |After Hours : 47.13 Down 0.29 (0.61%) Feb 27, 7:58PM EST
    Add to Portfolio
    ProfileGet Profile for:
    GlaxoSmithKline plc
    980 Great West Road
    Brentford, TW8 9GS
    United Kingdom - Map
    Phone: 44 20 8047 5000
    Website: http://www.gsk.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company’s wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company’s nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GlaxoSmithKline plc

    Key Executives 
     PayExercised
    Sir Andrew Philip Witty , 50
    Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    5.76M1.83M
    Mr. Simon Dingemans , 51
    Chief Financial Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    N/AN/A
    Dr. Moncef M. Slaoui Ph.D., 55
    Chairman of Global Vaccines, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    4.17M603.00K
    Mr. Daniel E. Troy ,
    Sr. VP and Gen. Counsel
    N/AN/A
    Mr. Philip C. Thomson ,
    Sr. VP of Communications & Gov. Affairs
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.